PH12020551712A1 - Tissue-specific methylation marker - Google Patents
Tissue-specific methylation markerInfo
- Publication number
- PH12020551712A1 PH12020551712A1 PH12020551712A PH12020551712A PH12020551712A1 PH 12020551712 A1 PH12020551712 A1 PH 12020551712A1 PH 12020551712 A PH12020551712 A PH 12020551712A PH 12020551712 A PH12020551712 A PH 12020551712A PH 12020551712 A1 PH12020551712 A1 PH 12020551712A1
- Authority
- PH
- Philippines
- Prior art keywords
- tissue
- cell
- compositions
- specific methylation
- methylation marker
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/30—Drug targeting using structural data; Docking or binding prediction
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Pathology (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862643649P | 2018-03-15 | 2018-03-15 | |
| US201862769928P | 2018-11-20 | 2018-11-20 | |
| PCT/US2019/022504 WO2019178496A1 (en) | 2018-03-15 | 2019-03-15 | Tissue-specific methylation marker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12020551712A1 true PH12020551712A1 (en) | 2021-06-21 |
Family
ID=67908065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12020551712A PH12020551712A1 (en) | 2018-03-15 | 2020-10-15 | Tissue-specific methylation marker |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11884966B2 (https=) |
| EP (1) | EP3766076A4 (https=) |
| JP (2) | JP7620803B2 (https=) |
| CN (2) | CN119955906A (https=) |
| AU (1) | AU2019233897B2 (https=) |
| CA (1) | CA3093971A1 (https=) |
| IL (1) | IL277306A (https=) |
| PH (1) | PH12020551712A1 (https=) |
| SG (1) | SG11202008957VA (https=) |
| TW (1) | TWI848941B (https=) |
| WO (1) | WO2019178496A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019233897B2 (en) | 2018-03-15 | 2024-10-24 | Grail, Inc. | Tissue-specific methylation marker |
| KR102103885B1 (ko) * | 2019-10-08 | 2020-04-24 | 주식회사 레피다인 | 생물학적 시료의 간 조직 유래 여부를 판별하는 방법 |
| KR102155044B1 (ko) * | 2019-10-08 | 2020-09-11 | 주식회사 레피다인 | 생물학적 시료의 간암 조직 기원 여부를 판별하는 방법 |
| EP4083232A4 (en) * | 2019-12-26 | 2024-03-20 | Anchordx Medical Co., Ltd. | COMBINATION OF DNA METHYLATION BIOMARKERS, AND ITS DETECTION METHOD AND ASSOCIATED KIT |
| GB2612447B (en) * | 2020-04-24 | 2025-08-13 | Univ Cornell | Methods for detecting tissue damage, graft versus host disease, and infections using cell-free DNA profiling |
| JP7646850B2 (ja) | 2021-02-09 | 2025-03-17 | エフ. ホフマン-ラ ロシュ アーゲー | 核酸中のメチル化の塩基レベル検出のための方法 |
| WO2023144704A1 (en) * | 2022-01-25 | 2023-08-03 | Gene Solutions Joint Stock Company | Systems and methods for detecting tumor dna in mammalian blood |
| US20250361549A1 (en) | 2022-06-14 | 2025-11-27 | Roche Sequencing Solutions, Inc. | Detection of epigenetic cytosine modification |
| WO2024112741A1 (en) * | 2022-11-23 | 2024-05-30 | Salk Institute For Biological Studies | Dna methylation barcodes for identifying brain cells |
| CN117476222B (zh) * | 2023-09-28 | 2024-10-25 | 上海交通大学医学院附属瑞金医院 | 一种肠癌肝转移的风险预测方法、系统和电子设备 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105243295B (zh) | 2010-11-30 | 2018-08-17 | 香港中文大学 | 与癌症相关的遗传或分子畸变的检测 |
| US9732390B2 (en) * | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| SI4056712T1 (sl) * | 2012-09-20 | 2024-10-30 | The Chinese University Of Hong Kong | Neinvazivno določanje metiloma tumorja iz plazme |
| US20160340740A1 (en) | 2014-01-30 | 2016-11-24 | The Regents Of The University Of California | Methylation haplotyping for non-invasive diagnosis (monod) |
| WO2015159292A2 (en) * | 2014-04-14 | 2015-10-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | A method and kit for determining the tissue or cell origin of dna |
| JP6681841B2 (ja) | 2014-05-09 | 2020-04-15 | ライフコーデックス アーゲー | 特別な細胞タイプに由来するdnaの検出とそれに関連する方法 |
| EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
| CA2951141C (en) | 2014-06-04 | 2021-11-30 | Quest Diagnostics Investments Incorporated | Methylated markers for colorectal cancer |
| TWI813141B (zh) | 2014-07-18 | 2023-08-21 | 香港中文大學 | Dna混合物中之組織甲基化模式分析 |
| CA3183545C (en) * | 2014-12-12 | 2026-01-13 | Exact Sciences Corporation | Compositions and methods for performing methylation detection assays |
| DK3408407T3 (da) | 2016-01-29 | 2021-02-08 | Epigenomics Ag | Fremgangsmåder til påvisning af cpg-methylering af tumorafledt dna i blodprøver |
| CN110168099B (zh) | 2016-06-07 | 2024-06-07 | 加利福尼亚大学董事会 | 用于疾病和病症分析的无细胞dna甲基化模式 |
| AU2019233897B2 (en) | 2018-03-15 | 2024-10-24 | Grail, Inc. | Tissue-specific methylation marker |
-
2019
- 2019-03-15 AU AU2019233897A patent/AU2019233897B2/en active Active
- 2019-03-15 JP JP2020548776A patent/JP7620803B2/ja active Active
- 2019-03-15 TW TW108108991A patent/TWI848941B/zh active
- 2019-03-15 CN CN202510148128.0A patent/CN119955906A/zh active Pending
- 2019-03-15 CN CN201980032333.3A patent/CN112534506B/zh active Active
- 2019-03-15 CA CA3093971A patent/CA3093971A1/en active Pending
- 2019-03-15 US US16/354,799 patent/US11884966B2/en active Active
- 2019-03-15 EP EP19768415.2A patent/EP3766076A4/en active Pending
- 2019-03-15 SG SG11202008957VA patent/SG11202008957VA/en unknown
- 2019-03-15 WO PCT/US2019/022504 patent/WO2019178496A1/en not_active Ceased
-
2020
- 2020-09-13 IL IL277306A patent/IL277306A/en unknown
- 2020-10-15 PH PH12020551712A patent/PH12020551712A1/en unknown
-
2023
- 2023-12-13 US US18/538,995 patent/US20240191282A1/en active Pending
-
2024
- 2024-07-08 JP JP2024109900A patent/JP2024156679A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TWI848941B (zh) | 2024-07-21 |
| CN112534506B (zh) | 2025-03-04 |
| KR20210023804A (ko) | 2021-03-04 |
| EP3766076A4 (en) | 2021-12-29 |
| US11884966B2 (en) | 2024-01-30 |
| TW202010845A (zh) | 2020-03-16 |
| US20240191282A1 (en) | 2024-06-13 |
| CN119955906A (zh) | 2025-05-09 |
| SG11202008957VA (en) | 2020-10-29 |
| JP7620803B2 (ja) | 2025-01-24 |
| EP3766076A1 (en) | 2021-01-20 |
| AU2019233897A1 (en) | 2020-10-22 |
| AU2019233897B2 (en) | 2024-10-24 |
| CN112534506A (zh) | 2021-03-19 |
| IL277306A (en) | 2020-10-29 |
| JP2024156679A (ja) | 2024-11-06 |
| WO2019178496A1 (en) | 2019-09-19 |
| CA3093971A1 (en) | 2019-09-19 |
| JP2021518107A (ja) | 2021-08-02 |
| US20190390257A1 (en) | 2019-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020551712A1 (en) | Tissue-specific methylation marker | |
| PH12020500103A1 (en) | Use of cas protein, method for detecting target nucleic acid molecule, and kit | |
| WO2019177684A8 (en) | Methods of quantifying rna and dna variants through sequencing employing phosphorothioates | |
| BR112018012374A2 (pt) | identificação, fabricação e uso de neoantígeno | |
| EP4667583A3 (en) | Multiple tagging of long dna fragments | |
| BR112018076259A2 (pt) | tagmentação usando transposomas imobilizados com ligantes | |
| SA521421271B1 (ar) | تركيبة وطريقة لثبات الأحماض النووية في عينات بيولوجية | |
| EP4631529A3 (en) | Application of click chemistry for signal amplification in ihc and ish assays | |
| BR112018076190A2 (pt) | ortólogos e sistemas crispr tipo vi | |
| EP4269577A3 (en) | Nucleobase editors and uses thereof | |
| SG10201903408VA (en) | Contiguity preserving transposition | |
| WO2016130704A3 (en) | Methods and compositions for analyzing cellular components | |
| MX386750B (es) | MARCADORES DE METILACIÓN Y DE miARN PARA LA DETECCIÓN DE CÁNCER. | |
| WO2008107134A3 (en) | A method for detection of liver cancer, risk of liver cancer, risk of recurrence of liver cancer, malignancy of liver cancer and progression of liver cancer with time by using the methylated cytosine in basp1 gene and/or srd5a2 gene | |
| EP2576839A4 (en) | NUCLEIC ACID STATEMENT AND QUANTIFICATION BY POSTHYBRIDISING LABELING AND UNIVERSAL ENCODING | |
| SG11201903066RA (en) | Method for multiplex detection of methylated dna | |
| EP4671381A3 (en) | Methods for synthesis and detection of nucleic acids | |
| EP4246144A3 (en) | Compositions and methods for screening mutations in thyroid cancer | |
| BR112014021993B8 (pt) | "métodos para detecção de uma variação de nucleotídeo em uma sequência de ácido nucleico alvo através de um ensaio de ptoce" | |
| CA2973769C (en) | Systems and methods for meso-dissection | |
| WO2019060914A3 (en) | Methods and systems for performing single cell analysis of molecules and molecular complexes | |
| WO2019094780A3 (en) | Non-coding rna for detection of cancer | |
| WO2009085196A8 (en) | Methods and compositions for correlating genetic markers with prostate cancer risk | |
| AU2018336160A1 (en) | Sex-linked genomic marker for crayfish and uses thereof | |
| SG11202011367TA (en) | Tumor marker, methylation detection reagent, kit and use thereof |